USDA approves the claim that the product is effective for the passive immunization of healthy dogs 13 weeks of age or older against canine parvovirus (CPV) disease
Results demonstrated 100% efficacy against the deadly disease, highlighting the potential to address a critical unmet medical need
PR Newswire
SAN FRANCISCO, April 28, 2021